More about Maxion Therapeutics
Maxion Therapeutics is a biotechnology company based in Cambridge, UK, founded in 2020. The company specializes in developing innovative protein therapeutics aimed at treating diseases driven by ion channels and G protein-coupled receptors (GPCRs). Their focus includes conditions such as chronic pain, autoimmune disorders, cardiovascular disease, atopic dermatitis, and inflammatory bowel disease. The company utilizes its proprietary KnotBody® technology, which combines venom-derived peptides with antibodies to create therapeutics that are potent, selective, and long-acting. Maxion is advancing a preclinical pipeline that includes its lead program, MAX001, targeting inflammatory diseases, along with early-stage programs addressing pain and cardiovascular issues. The leadership team includes experienced professionals from notable biotech backgrounds, and the company has successfully raised significant funding to support its research and development efforts.
Live roles
Alert me when Maxion Therapeutics posts a new role Email me when this changes
Similar Cambridge companies
Full directory →- Kymab / Sanofi Cambridge 47 live
- AstraZeneca 13 live
Cambridge-headquartered global pharma; major presence at the Cambridge Biomedical Campus. Heavy AI/ML hiring across genetics, drug discovery and biologics engineering.
- GSK 6 live
Global pharma; Stevenage R&D campus is the company's largest UK research site. Active in AI/ML for drug discovery, translational data, and oncology pharmacology.
- Illumina 6 live
Cambridge-based (Chesterford Research Park) arm of Illumina developing DNA sequencing instruments and technology.
- Tailor Bio 4 live
- Healx 2 live
Cambridge AI-for-rare-disease scale-up; ML platform for drug repurposing and combination discovery. Strong ML/data hiring track record.